Mold-Tek Packaging Approves 1:1 Bonus Equity Share Issue

Market snapshot: Mold-Tek Packaging's Board of Directors has officially approved the issuance of fully paid-up bonus equity shares in a 1:1 ratio. Along with the bonus shares, the board recommended a final dividend of ₹3 per share and proposed doubling its authorised share capital to ₹40 crore to facilitate this equity expansion.

Data Snapshot

• The Board of Directors approved a 1:1 bonus issue of 3,32,28,914 equity shares with a face value of ₹5 each.
• The total value of the bonus shares to be issued is ₹16.61 crore, which will be capitalized from the company's free reserves as of March 31, 2026.
• The board recommended a final dividend of ₹3 per share (60% of face value) for the financial year ended March 31, 2026.
• The company proposed to increase its authorised share capital from ₹20 crore to ₹40 crore to accommodate the equity expansion.

What's Changed

• The total share count will double from 4 crore shares to 8 crore shares post-completion.
• Authorised share capital is set to double from ₹20 crore to ₹40 crore (derived: increase of ₹20 crore).
• Free reserves as of March 31, 2026, will be reduced by ₹16.61 crore to fund the fully paid bonus issue.

Key Takeaways

• The 1:1 bonus issue will double the company's outstanding equity shares, improving stock liquidity and retail participation.
• The recommended ₹3 final dividend represents a strong 60% payout on the face value of ₹5 per share.
• Doubling the authorised share capital to ₹40 crore provides the necessary structural space for the new shares.
• Capitalizing ₹16.61 crore from free reserves highlights the strength of the company's balance sheet.

SAHI Perspective

The board's simultaneous approval of a 1:1 bonus issue, a ₹3 final dividend, and a doubling of authorised share capital reflects management's strong confidence in the company's earnings visibility. By capitalizing ₹16.61 crore from its free reserves, Mold-Tek leverages its healthy balance sheet to improve stock liquidity and expand its retail investor base. This structural expansion aligns with the company's recent strategic initiatives, including its high-margin pharma division scale-up.

Market Implications

The bonus issue will half the absolute market price on the ex-bonus date, resolving retail accessibility barriers. Doubling the share count typically leads to higher daily trading volumes. The final dividend payout of ₹3 per share provides immediate cash yield to investors, reinforcing the company's shareholder-friendly capital allocation policies.

Trading Signals

Market Bias: Bullish

The combination of a 1:1 bonus issue and a ₹3 final dividend indicates robust liquidity and a positive management outlook, backed by a strong Q1 FY27 net profit of ₹25.57 crore.

Overweight: Packaging, FMCG Packaging

Trigger Factors:

• Official announcement of the ex-bonus and record dates for the 1:1 share distribution.
• Shareholder approval of the bonus issue and final dividend at the upcoming AGM.
• Sustained volume growth in the high-margin pharmaceutical packaging segment.

Time Horizon: Near-term (0-3 months)

Industry Context

India's rigid plastic packaging sector is witnessing a shift toward value-added packaging formats such as In-Mould Labelling (IML). Mold-Tek Packaging remains an industry leader in this niche, serving prominent clients across paints, lubricants, and FMCG sectors. The company's expansion into high-margin pharmaceutical and medical device packaging, backed by a planned ₹90 crore CapEx for FY27, is expected to drive higher EBITDA margins, which recently achieved a historic high of ₹46.68 per kg in Q1 FY27.

Key Risks to Watch

• Geopolitical or supply chain disruptions affecting raw material (polymer) pricing.
• Execution risks related to the integration of the consolidated Hyderabad units and new pharma packaging plants.
• Slower-than-expected client off-take in the newly introduced food and FMCG packaging lines.

Recent Developments

On July 27, 2026, Mold-Tek Packaging reported Q1 FY27 results with revenue rising 24.90% YoY to ₹300.45 crore and net profit increasing 14.15% YoY to ₹25.57 crore. The company also announced a ₹90 crore CapEx plan for FY27 to scale its pharma and medical packaging divisions. Around July 30, 2026, Mold-Tek signed a memorandum of understanding (MoU) with UK-based Vibe Generation Holdings to commercialize safety-enhanced closures.

Closing Insight

Mold-Tek Packaging's dual move of a bonus issue and a healthy final dividend demonstrates corporate maturity. By restructuring its capital base while aggressively expanding into higher-margin pharma segments, the company positions itself well for sustainable long-term value creation.

High Performance Trading with SAHI.